Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients

NCT04055948 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 484

Last updated 2026-03-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to learn whether an education and support program can help caregivers feel more confident in technical and communication skills needed to care for a person with cancer. Patients with cancer and their caregivers face many challenges. These include learning about cancer and its treatment, coping with symptoms from illness and treatment side effects, making adjustments to usual activities, and managing the emotional effects of having a serious illness. This study is testing whether different forms of education and support can help caregivers feel better prepared. To find out if education about caregiving and different kinds of support are effective, study personnel will compare approaches to help find ways to improve the services that are provided to caregivers during cancer treatment. About 180 patients and their caregivers at the Seidman Cancer Center will take part in this study. Participating in research is voluntary and this study is funded by the National Institute of Health.

Conditions

Interventions

BEHAVIORAL

One-on-one support/educational sessions

One-on-one support/educational sessions with the caregiver during radiation treatments (note - intervention sessions 2 \& 3 delivered by phone during COVID-19 and remained an option after the pandemic).

BEHAVIORAL

Telephone booster contact

Telephone booster contact 2 weeks post-treatment.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Susan Mazanec, PhD, RN · Case Western Reserve University, Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-17
Primary Completion
2025-02-01
Completion
2025-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04055948 on ClinicalTrials.gov